Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Scientific Reports
|
March 14, 2020
Identification of highly potent and selective inhibitor, TIPTP, of the p22phox-Rubicon axis as a therapeutic agent for rheumatoid arthritis
Ye-Ram Kim, Jae-Sung Kim, Su-Jin Gu, et al.
International Journal of Molecular Medicine
|
February 6, 2026
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer
Eunsun Jung, Ji Young Kim, Dongmi Ko, et al.
The Oncologist
|
March 29, 2022
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology
Cyra Y Kang, Samantha E Duarte, Hye Sung Kim, et al.
International Journal of Environmental Research and Public Health
|
April 3, 2021
Daily Life Changes and Life Satisfaction among Korean School-Aged Children in the COVID-19 Pandemic
Jihye Choi, Youjeong Park, Hye-Eun Kim, et al.
Journal of Medicinal Chemistry
|
January 4, 2022
Discovery of <i>Mycobacterium tuberculosis</i> Rv3364c-Derived Small Molecules as Potential Therapeutic Agents to Target SNX9 for Sepsis
Daeun Lee, Eunbi Lee, Sein Jang, et al.
Journal of Toxicology and Environmental Health. Part A
|
June 30, 2021
Exposure to lead on expression levels of brain immunoglobulins, inflammatory cytokines, and brain-derived neurotropic factor in fetal and postnatal mice with autism-like characteristics
KyeongMin Shin, GyeongDong Lim, Young-Seoub Hong, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Scientific Reports
|
March 14, 2020
Identification of highly potent and selective inhibitor, TIPTP, of the p22phox-Rubicon axis as a therapeutic agent for rheumatoid arthritis
Ye-Ram Kim, Jae-Sung Kim, Su-Jin Gu, et al.
International Journal of Molecular Medicine
|
February 6, 2026
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer
Eunsun Jung, Ji Young Kim, Dongmi Ko, et al.
The Oncologist
|
March 29, 2022
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology
Cyra Y Kang, Samantha E Duarte, Hye Sung Kim, et al.
International Journal of Environmental Research and Public Health
|
April 3, 2021
Daily Life Changes and Life Satisfaction among Korean School-Aged Children in the COVID-19 Pandemic
Jihye Choi, Youjeong Park, Hye-Eun Kim, et al.
Journal of Medicinal Chemistry
|
January 4, 2022
Discovery of <i>Mycobacterium tuberculosis</i> Rv3364c-Derived Small Molecules as Potential Therapeutic Agents to Target SNX9 for Sepsis
Daeun Lee, Eunbi Lee, Sein Jang, et al.
Journal of Toxicology and Environmental Health. Part A
|
June 30, 2021
Exposure to lead on expression levels of brain immunoglobulins, inflammatory cytokines, and brain-derived neurotropic factor in fetal and postnatal mice with autism-like characteristics
KyeongMin Shin, GyeongDong Lim, Young-Seoub Hong, et al.
Page
of 6